Risk factor
Low price volatility
Profitability factor
Greatly undervalued vs peers
About
PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBITDA, unde
Target Price
The average target price of 6523.T is 1373 and suggests 8.65% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendat